BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15881703)

  • 1. [von Hippel-Lindau syndrome: molecular diagnosis of two Lebanese families and analysis of the genotype-phenotype correlation].
    Medlej-Hashim M; Leclercq A; Salem N; Moukarzel M; Merhej S; Pigny P; Megarbane A
    J Med Liban; 2004; 52(1):51-4. PubMed ID: 15881703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Von Hippel-Lindau disease and molecular genetic diagnosis].
    Jensen AM; Bisgaard ML
    Ugeskr Laeger; 1999 Feb; 161(7):959-61. PubMed ID: 10051806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
    Hes FJ; van der Luijt RB
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [von Hippel-Lindau hereditary tumor syndrome. Mutational analysis may improve prognosis].
    Wiklund L; Nordling M; Engwall Y; Martinsson T; Szentgyörgyi E; Wahlström J
    Lakartidningen; 1995 Mar; 92(11):1093-6. PubMed ID: 7700111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
    Richard S; Beroud C; Joly D; Chretien Y; Benoit G
    Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
    Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
    J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
    Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
    Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.
    Wait SD; Vortmeyer AO; Lonser RR; Chang DT; Finn MA; Bhowmick DA; Pack SD; Oldfield EH; Zhuang Z
    Ann Neurol; 2004 Feb; 55(2):236-40. PubMed ID: 14755727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of the von Hippel-Lindau disease in three spanish families].
    Villar Gómez de las Heras K
    An Med Interna; 2002 Jul; 19(7):352-6. PubMed ID: 12224143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; Von Hippel-Lindau disease].
    Hes FJ; Los M; van der Luijt RB
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1364-7. PubMed ID: 12162174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
    Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
    Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The history of von Hippel-Lindau disease.
    Molino D; Sepe J; Anastasio P; De Santo NG
    J Nephrol; 2006; 19 Suppl 10():S119-23. PubMed ID: 16874724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Hippel-Lindau disease: a genetic condition predisposing tumor formation.
    Martz CH
    Oncol Nurs Forum; 1991 Apr; 18(3):545-51. PubMed ID: 2057398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
    Richard S;
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a de novo mutation in a patient without von Hippel-Lindau syndrome: clinical and diagnostic implications].
    Cebrián A; Ruiz Barnés P; Osorio A; Martínez-Delgado B; Benítez J; Robledo M
    Neurologia; 1999; 14(7):362-5. PubMed ID: 10570625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
    Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
    Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The von Hippel-Lindau syndrome with pheochromocytoma].
    Palmar I; Vircburger M; Manojlović D; Radević B; Andjelković Z; Burić B; Savicević M; Nesković G
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():43-6. PubMed ID: 12584997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.